These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9802552)
21. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Lynch SM; Campione AL; Moore MK Biochim Biophys Acta; 2000 May; 1485(1):11-22. PubMed ID: 10802245 [TBL] [Abstract][Full Text] [Related]
22. Increased levels of monohydroxy metabolites of arachidonic acid and linoleic acid in LDL and aorta from atherosclerotic rabbits. Wang T; Powell WS Biochim Biophys Acta; 1991 Jul; 1084(2):129-38. PubMed ID: 1854797 [TBL] [Abstract][Full Text] [Related]
23. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis. Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235 [TBL] [Abstract][Full Text] [Related]
24. Modified low density lipoprotein isolated from atherosclerotic lesions does not cause lipid accumulation in aortic smooth muscle cells. Hoff HF; Pepin JM; Morton RE J Lipid Res; 1991 Jan; 32(1):115-24. PubMed ID: 2010683 [TBL] [Abstract][Full Text] [Related]
25. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Morel DW; DiCorleto PE; Chisolm GM Arteriosclerosis; 1984; 4(4):357-64. PubMed ID: 6466193 [TBL] [Abstract][Full Text] [Related]
26. Hypersusceptibility of neutrophil granulocytes towards lethal action of free fatty acids contained in enzyme-modified atherogenic low density lipoprotein. Lux CA; Koschinski A; Dersch K; Husmann M; Bhakdi S Atherosclerosis; 2009 Nov; 207(1):116-22. PubMed ID: 19423111 [TBL] [Abstract][Full Text] [Related]
27. Macrophage-enhanced formation of cholesteryl ester-core aldehydes during oxidation of low density lipoprotein. Karten B; Boechzelt H; Abuja PM; Mittelbach M; Sattler W J Lipid Res; 1999 Jul; 40(7):1240-53. PubMed ID: 10393209 [TBL] [Abstract][Full Text] [Related]
28. Lipopolysaccharide enhances oxidative modification of low density lipoprotein by copper ions, endothelial and smooth muscle cells. Maziere C; Conte MA; Dantin F; Maziere JC Atherosclerosis; 1999 Mar; 143(1):75-80. PubMed ID: 10208481 [TBL] [Abstract][Full Text] [Related]
29. Glomerular macrophages in nephrotoxic serum nephritis are activated to oxidize low-density lipoprotein. Rie J; Silbiger S; Neugarten J Am J Kidney Dis; 1995 Aug; 26(2):362-7. PubMed ID: 7645542 [TBL] [Abstract][Full Text] [Related]
30. Cells derived from regenerated endothelium of the porcine coronary artery contain more oxidized forms of apolipoprotein-B-100 without a modification in the uptake of oxidized LDL. Kennedy S; Fournet-Bourguignon MP; Breugnot C; Castedo-Delrieu M; Lesage L; Reure H; Briant C; Leonce S; Vilaine JP; Vanhoutte PM J Vasc Res; 2003; 40(4):389-98. PubMed ID: 12904688 [TBL] [Abstract][Full Text] [Related]
31. Effect of the oxidation state of LDL on the modulation of arterial vasomotor response in vitro. Mougenot N; Lesnik P; Ramirez-Gil JF; Nataf P; Diczfalusy U; Chapman MJ; Lechat P Atherosclerosis; 1997 Sep; 133(2):183-92. PubMed ID: 9298678 [TBL] [Abstract][Full Text] [Related]
32. Formation of F2-isoprostanes during aortic endothelial cell-mediated oxidation of low density lipoprotein. Gopaul NK; Nourooz-Zadeh J; Mallet AI; Anggård EE FEBS Lett; 1994 Jul; 348(3):297-300. PubMed ID: 8034058 [TBL] [Abstract][Full Text] [Related]
33. Oxidation of lipoproteins and atherosclerosis. Luc G; Fruchart JC Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389 [TBL] [Abstract][Full Text] [Related]
34. Enhanced capacity of n-3 fatty acid-enriched macrophages to oxidize low density lipoprotein mechanisms and effects of antioxidant vitamins. Suzukawa M; Abbey M; Clifton P; Nestel PJ Atherosclerosis; 1996 Aug; 124(2):157-69. PubMed ID: 8830929 [TBL] [Abstract][Full Text] [Related]
35. Differential toxicities of air (mO-LDL) or copper-oxidized LDLs (Cu-LDL) toward endothelial cells. Furman C; Martin-Nizard F; Fruchart JC; Duriez P; Teissier E J Biochem Mol Toxicol; 1999; 13(6):316-23. PubMed ID: 10487419 [TBL] [Abstract][Full Text] [Related]
36. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins. Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762 [TBL] [Abstract][Full Text] [Related]
37. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells. Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926 [TBL] [Abstract][Full Text] [Related]
38. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Clinton SK; Underwood R; Hayes L; Sherman ML; Kufe DW; Libby P Am J Pathol; 1992 Feb; 140(2):301-16. PubMed ID: 1739124 [TBL] [Abstract][Full Text] [Related]
39. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Gniwotta C; Morrow JD; Roberts LJ; Kühn H Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3236-41. PubMed ID: 9409317 [TBL] [Abstract][Full Text] [Related]